drug
as of 2026-07-01weight management program
Weight Management Program
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Eli Lilly and Company
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
Trials
2
The Effect of a Weight Management Program During Treatment With Olanzapine
NCT00169702—Completed
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
NCT00485823Phase 4Completed
KOLs & investigators
4
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Joachim Cordes, MD
personKOL score 4
Ansgar Klimke, Prof
personKOL score —
Hans Hauner, Prof
personKOL score —